Effect of dapagliflozin on cardiovascular events in patients with type 2 diabetes
- Resource Type
- Source
- Drug and Therapeutics Bulletin. 59:22-23
- Subject
medicine.medical_specialty Clinical pharmacology business.industry General Medicine Type 2 diabetes 030204 cardiovascular system & hematology medicine.disease law.invention Associate editor 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry law Diabetes mellitus Internal medicine medicine Pharmacology (medical) In patient 030212 general & internal medicine Dapagliflozin business Cardiovascular outcomes - Language
- ISSN
- 1755-5248
0012-6543